Report Detail
Global (United States, European Union and China) Acute Ischemic Stroke Therapeutics Market Research Report 2019-2025
- RnM3675149 |
- 16 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics market is expected to register a low single digit market growth during the forecast period. The marginal growth rate is attributed to the lack of approved drugs in this area, the presence of alternative therapies, extensive use of generics, and unmet needs for anticoagulant reversal agents.
Technavio's analysts forecast the global acute ischemic stroke therapeutics market to grow at a CAGR of 2.11% during the period 2017-2025.
In 2019, the market size of Acute Ischemic Stroke Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of 0.021 from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Acute Ischemic Stroke Therapeutics.
This report studies the global market size of Acute Ischemic Stroke Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Acute Ischemic Stroke Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bayer
Boehringer Ingelheim
Roche
Sanofi
Biogen
Daiichi Sankyo
Pfizer
...
Market Segment by Product Type
Thrombolytic Therapeutics
Antihypertensive Therapeutics
Antiplatelet Therapeutics
Anticoagulants
Market Segment by Application
Hospitals
Ambulatory Surgical Center
Diagnostic Centers
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Acute Ischemic Stroke Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Acute Ischemic Stroke Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Acute Ischemic Stroke Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Acute Ischemic Stroke Therapeutics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Thrombolytic Therapeutics
- 1.3.3 Antihypertensive Therapeutics
- 1.3.4 Antiplatelet Therapeutics
- 1.3.5 Anticoagulants
- 1.4 Market Segment by Application
- 1.4.1 Global Acute Ischemic Stroke Therapeutics Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Ambulatory Surgical Center
- 1.4.4 Diagnostic Centers
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Acute Ischemic Stroke Therapeutics Market Size
- 2.1.1 Global Acute Ischemic Stroke Therapeutics Revenue 2014-2025
- 2.1.2 Global Acute Ischemic Stroke Therapeutics Sales 2014-2025
- 2.2 Acute Ischemic Stroke Therapeutics Growth Rate by Regions
- 2.2.1 Global Acute Ischemic Stroke Therapeutics Sales by Regions 2014-2019
- 2.2.2 Global Acute Ischemic Stroke Therapeutics Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Acute Ischemic Stroke Therapeutics Sales by Manufacturers
- 3.1.1 Acute Ischemic Stroke Therapeutics Sales by Manufacturers 2014-2019
- 3.1.2 Acute Ischemic Stroke Therapeutics Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Acute Ischemic Stroke Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Acute Ischemic Stroke Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Acute Ischemic Stroke Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.3 Acute Ischemic Stroke Therapeutics Price by Manufacturers
- 3.4 Key Manufacturers Acute Ischemic Stroke Therapeutics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Acute Ischemic Stroke Therapeutics Market
- 3.6 Key Manufacturers Acute Ischemic Stroke Therapeutics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Thrombolytic Therapeutics Sales and Revenue (2014-2019)
- 4.1.2 Antihypertensive Therapeutics Sales and Revenue (2014-2019)
- 4.1.3 Antiplatelet Therapeutics Sales and Revenue (2014-2019)
- 4.1.4 Anticoagulants Sales and Revenue (2014-2019)
- 4.2 Global Acute Ischemic Stroke Therapeutics Sales Market Share by Type
- 4.3 Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Type
- 4.4 Acute Ischemic Stroke Therapeutics Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Acute Ischemic Stroke Therapeutics Sales by Application
6 United States
- 6.1 United States Acute Ischemic Stroke Therapeutics Breakdown Data by Company
- 6.2 United States Acute Ischemic Stroke Therapeutics Breakdown Data by Type
- 6.3 United States Acute Ischemic Stroke Therapeutics Breakdown Data by Application
7 European Union
- 7.1 European Union Acute Ischemic Stroke Therapeutics Breakdown Data by Company
- 7.2 European Union Acute Ischemic Stroke Therapeutics Breakdown Data by Type
- 7.3 European Union Acute Ischemic Stroke Therapeutics Breakdown Data by Application
8 China
- 8.1 China Acute Ischemic Stroke Therapeutics Breakdown Data by Company
- 8.2 China Acute Ischemic Stroke Therapeutics Breakdown Data by Type
- 8.3 China Acute Ischemic Stroke Therapeutics Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Acute Ischemic Stroke Therapeutics Breakdown Data by Company
- 9.2 Rest of World Acute Ischemic Stroke Therapeutics Breakdown Data by Type
- 9.3 Rest of World Acute Ischemic Stroke Therapeutics Breakdown Data by Application
- 9.4 Rest of World Acute Ischemic Stroke Therapeutics Breakdown Data by Countries
- 9.4.1 Rest of World Acute Ischemic Stroke Therapeutics Sales by Countries
- 9.4.2 Rest of World Acute Ischemic Stroke Therapeutics Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Bayer
- 10.1.1 Bayer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Acute Ischemic Stroke Therapeutics
- 10.1.4 Acute Ischemic Stroke Therapeutics Product Introduction
- 10.1.5 Bayer Recent Development
- 10.2 Boehringer Ingelheim
- 10.2.1 Boehringer Ingelheim Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Acute Ischemic Stroke Therapeutics
- 10.2.4 Acute Ischemic Stroke Therapeutics Product Introduction
- 10.2.5 Boehringer Ingelheim Recent Development
- 10.3 Roche
- 10.3.1 Roche Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Acute Ischemic Stroke Therapeutics
- 10.3.4 Acute Ischemic Stroke Therapeutics Product Introduction
- 10.3.5 Roche Recent Development
- 10.4 Sanofi
- 10.4.1 Sanofi Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Acute Ischemic Stroke Therapeutics
- 10.4.4 Acute Ischemic Stroke Therapeutics Product Introduction
- 10.4.5 Sanofi Recent Development
- 10.5 Biogen
- 10.5.1 Biogen Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Acute Ischemic Stroke Therapeutics
- 10.5.4 Acute Ischemic Stroke Therapeutics Product Introduction
- 10.5.5 Biogen Recent Development
- 10.6 Daiichi Sankyo
- 10.6.1 Daiichi Sankyo Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Acute Ischemic Stroke Therapeutics
- 10.6.4 Acute Ischemic Stroke Therapeutics Product Introduction
- 10.6.5 Daiichi Sankyo Recent Development
- 10.7 Pfizer
- 10.7.1 Pfizer Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Acute Ischemic Stroke Therapeutics
- 10.7.4 Acute Ischemic Stroke Therapeutics Product Introduction
- 10.7.5 Pfizer Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Acute Ischemic Stroke Therapeutics Sales Channels
- 11.2.2 Acute Ischemic Stroke Therapeutics Distributors
- 11.3 Acute Ischemic Stroke Therapeutics Customers
12 Market Forecast
- 12.1 Global Acute Ischemic Stroke Therapeutics Sales and Revenue Forecast 2019-2025
- 12.2 Global Acute Ischemic Stroke Therapeutics Sales Forecast by Type
- 12.3 Global Acute Ischemic Stroke Therapeutics Sales Forecast by Application
- 12.4 Acute Ischemic Stroke Therapeutics Forecast by Regions
- 12.4.1 Global Acute Ischemic Stroke Therapeutics Sales Forecast by Regions 2019-2025
- 12.4.2 Global Acute Ischemic Stroke Therapeutics Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Acute Ischemic Stroke Therapeutics. Industry analysis & Market Report on Acute Ischemic Stroke Therapeutics is a syndicated market report, published as Global (United States, European Union and China) Acute Ischemic Stroke Therapeutics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Acute Ischemic Stroke Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
